Phase I and pharmacokinetic study of elacytarabine, a novel 5'-elaidic acid derivative of cytarabine, in adults with refractory hematological malignancies.
F J
FJ
Giles
N
N
Vey
D
D
Rizzieri
F
F
Ravandi
T
T
Prebet
G
G
Borthakur
T F
TF
Jacobsen
S
S
Hagen
B
B
Nilsson
S
S
O'Brien
D000328:Adult; D003561:Cytarabine / Q000031:analogs & derivatives* / Q000097:blood / Q000493:pharmacokinetics / Q000627:therapeutic use; D019337:Hematologic Neoplasms / Q000188:drug therapy*; D006801:Humans; D008875:Middle Aged; D011379:Prognosis; D014018:Tissue Distribution
D003561:Cytarabine; C047645:5'-oleoyl cytarabine